Table 3.
The relative risks of donor site morbidity and flap complications across different breast reconstruction techniques.
| Donor hernia/bulge | Donor wound infection | ||||||
| FTRAM | FTRAM | ||||||
| 0.43 (0.24–0.77) | PTRAM | 0.82 (0.60–1.13) | PTRAM | ||||
| 3.66 (0.65–20.74) | 8.53 (1.42–51.32) | SIEA | 0.27 (0.12–0.61) | 0.33 (0.15–0.73) | SIEA | ||
| 1.43 (0.92–2.23) | 3.34 (1.79–6.23) | 0.39 (0.07–2.26) | DIEP | 1.20 (0.87–1.64) | 1.45 (1.08–1.95) | 4.47 (2.02–9.88) | DIEP |
|
| |||||||
| Flap fat necrosis | Mastectomy flap necrosis | ||||||
| FTRAM | FTRAM | ||||||
| 0.35 (0.17–0.74) | PTRAM | 0.77 (0.35–1.70) | PTRAM | ||||
| 0.45 (0.21–0.97) | 1.29 (0.50–3.30) | SIEA | 0.82 (0.35–1.93) | 1.07 (0.41–2.74) | SIEA | ||
| 0.60 (0.38–0.95) | 1.71 (0.88–3.32) | 1.33 (0.62–2.83) | DIEP | 0.90 (0.53–1.53) | 1.17 (0.62–2.21) | 1.10 (0.50–2.38) | DIEP |
|
| |||||||
| Partial flap loss | Total flap loss | ||||||
| FTRAM | FTRAM | ||||||
| 0.61 (0.28–1.35) | PTRAM | 0.78 (0.29–2.05) | PTRAM | ||||
| 0.73 (0.23–2.36) | 1.19 (0.35–4.09) | SIEA | 0.46 (0.15–1.41) | 0.59 (0.16–2.10) | SIEA | ||
| 0.88 (0.46–1.69) | 1.44 (0.69–2.98) | 1.20 (0.37–3.96) | DIEP | 0.53 (0.26–1.08) | 0.68 (0.27–1.68) | 1.15 (0.37–3.61) | DIEP |
|
| |||||||
| Flap hematoma | Flap total thrombotic event | ||||||
| FTRAM | FTRAM | ||||||
| 1.04 (0.54–1.99) | PTRAM | 0.23 (0.07–0.68) | SIEA | ||||
| 0.37 (0.19–0.72) | 0.36 (0.17–0.74) | SIEA | 0.18 (0.05–0.63) | 0.79 (0.24–2.63) | DIEP | ||
| 0.54 (0.32–0.89) | 0.52 (0.29–0.93) | 1.45 (0.76–2.75) | DIEP | ||||
|
| |||||||
| Flap wound infection | |||||||
| FTRAM | |||||||
| 0.38 (0.16–0.88) | PTRAM | ||||||
| 1.17 (0.45–3.02) | 3.10 (0.99–9.65) | SIEA | |||||
| 0.59 (0.29–1.23) | 1.57 (0.94–2.61) | 0.51 (0.18–1.45) | DIEP | ||||
Data are expressed as relative risks (95% confidence intervals). The outcomes can be interpreted from the left to right direction to indicate low/high risks.